<DOC>
	<DOCNO>NCT00406848</DOCNO>
	<brief_summary>The purpose study compare efficacy safety duloxetine 60 mg daily placebo depression elderly patient ( great equal 65 year age ) . Patients respond first 13 week eligible rescue use pre-defined criterion . Patients randomize duloxetine 60 mg/day meeting rescue criterion increase 120 mg/day . Patients randomize placebo arm meeting rescue criterion assign duloxetine 60 mg/day .</brief_summary>
	<brief_title>A Study Comparing Efficacy Safety Duloxetine Placebo Treatment Depression Elderly Patients</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Are male female outpatient least 65 year age meet Diagnostic Statistical Manual Mental Disorders Fourth Edition Text Revision ( DSMIVTR ) diagnostic criterion Major Depressive Disorder ( MDD ) Have Mini Mental Score Exam ( MMSE ) score least 20 Visit 1 Have degree understand patient communicate intelligibly investigator study coordinator Patients judge clinically serious suicidal risk opinion investigator Have prior history bipolar disorder , panic disorder , psychosis , schizophrenia , obsessivecompulsive disorder Have current ( within past 12 month ) DSMIVTR primary Axis I diagnosis MDD Have moderate severe dementia Have serious medical illness , include cardiovascular ( CV ) , hepatic , renal , respiratory , hematologic , endocrinologic , neurologic disease , clinically significant laboratory abnormality stabilize anticipated require hospitalization within 6 month , opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>